4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-15-000614
$ACADCIK 0001070494operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:58 PM ET
Size
12.0 KB
Accession
0001415889-15-000614
Insider Transaction Report
Form 4
Hacksell Uli
DirectorCEO
Transactions
- Gift
Common Stock
2015-02-17−30,000→ 0 total - Exercise/Conversion
Common Stock
2015-02-17$1.55/sh+30,000$46,500→ 30,000 total - Gift
Common Stock
2015-02-17+30,000→ 145,549 total(indirect: By Trust) - Sale
Common Stock
2015-02-17$34.30/sh−30,000$1,028,868→ 115,549 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2015-02-17−30,000→ 313,500 totalExercise: $1.55Exp: 2020-03-11→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2014.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $34.52 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]25% of the shares subject to the stock option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:58 PM ET
- Size
- 12.0 KB